Condition
Reverse Shoulder Replacement
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06869343Not ApplicableRecruiting
Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture
NCT06873022Not ApplicableRecruitingPrimary
EMG Biofeedback and NMES of Deltoid in Patients With rTSA
NCT04474665Not ApplicableUnknownPrimary
Tornier Blueprint Planning Software in Patients Receiving Reverse Shoulder Arthroplasty
Showing all 3 trials